Literature DB >> 25256692

Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults.

Paul Murphy1, Jonathan Hooker1, Brandon Ang2, Tanya Wolfson3, Anthony Gamst3, Mark Bydder1, Michael Middleton1, Michael Peterson4, Cynthia Behling5, Rohit Loomba2,6, Claude Sirlin1.   

Abstract

PURPOSE: To investigate in adults the associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative measures derived from diffusion-weighted imaging (DWI).
MATERIALS AND METHODS: Eighty-nine adults undergoing standard-of-care liver biopsy for NAFLD were recruited for DWI. Biopsies were scored for histologic features of NAFLD. DWI was performed using b-values of 0, 100, and 500 s/mm(2) . Images were reconstructed using either conventional magnitude averaging (CMA) or a method to address bulk motion artifacts (Beta*LogNormal, BLN). The apparent diffusion coefficient (ADC) and the diffusivity (D) and perfusion fraction (F) of the intravoxel incoherent motion (IVIM) model were measured in the right hepatic lobe using both reconstructions. Associations between histologic features and DWI-derived measures were tested statistically with several methods including multiple linear regression.
RESULTS: Using CMA and BLN reconstructions, respectively, the means (and ranges) were 1.7 (1.1-3.5) and 1.4 (1.0-3.2) × 10(-3) mm(2) /s for ADC, 1.1 (0.84-1.4) and 0.84 (0.53-1.1) × 10(-3) mm(2) /s for D, and 17 and 18 (2.3-35)% for F. For both reconstruction methods, D decreased with steatosis and F decreased with fibrosis (P < 0.05). ADC was not independently associated with any histologic feature.
CONCLUSION: Steatosis and fibrosis have significant independent effects on D and F in adults undergoing biopsy for NAFLD.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  DWI; IVIM; NAFLD; NASH; diffusion; liver

Mesh:

Year:  2014        PMID: 25256692      PMCID: PMC4819971          DOI: 10.1002/jmri.24755

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  32 in total

1.  Diffusion-weighted MRI of fatty liver.

Authors:  Ahmet K Poyraz; Mehmet R Onur; Ercan Kocakoç; Erkin Oğur
Journal:  J Magn Reson Imaging       Date:  2011-12-14       Impact factor: 4.813

2.  The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Anna Mae Diehl; Elizabeth M Brunt; Kenneth Cusi; Michael Charlton; Arun J Sanyal
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

3.  Cardiac motion in diffusion-weighted MRI of the liver: artifact and a method of correction.

Authors:  Joy Liau; Jimmy Lee; Michael E Schroeder; Claude B Sirlin; Mark Bydder
Journal:  J Magn Reson Imaging       Date:  2011-09-29       Impact factor: 4.813

4.  Cross-sectional investigation of correlation between hepatic steatosis and IVIM perfusion on MR imaging.

Authors:  James T Lee; Joy Liau; Paul Murphy; Michael E Schroeder; Claude B Sirlin; Mark Bydder
Journal:  Magn Reson Imaging       Date:  2012-01-27       Impact factor: 2.546

5.  Effect of disease progression on liver apparent diffusion coefficient values in a murine model of NASH at 11.7 Tesla MRI.

Authors:  Stephan W Anderson; Jorge A Soto; Holly N Milch; Al Ozonoff; Michael O'Brien; James A Hamilton; Hernan J Jara
Journal:  J Magn Reson Imaging       Date:  2011-04       Impact factor: 4.813

6.  Liver diffusivity in healthy volunteers and patients with chronic liver disease: comparison of breathhold and free-breathing techniques.

Authors:  Mamak Eatesam; Susan M Noworolski; Phyllis C Tien; Michelle Nystrom; Jennifer L Dodge; Raphael B Merriman; Aliya Qayyum
Journal:  J Magn Reson Imaging       Date:  2011-10-27       Impact factor: 4.813

7.  Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis.

Authors:  Rohit Loomba; Maria Abraham; Aynur Unalp; Laura Wilson; Joel Lavine; Ed Doo; Nathan M Bass
Journal:  Hepatology       Date:  2012-07-26       Impact factor: 17.425

8.  Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.

Authors:  Elizabeth M Brunt; David E Kleiner; Laura A Wilson; Patricia Belt; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

9.  Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.

Authors:  Z Permutt; T-A Le; M R Peterson; E Seki; D A Brenner; C Sirlin; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2012-05-03       Impact factor: 8.171

10.  Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial.

Authors:  Thuy-Anh Le; Joshua Chen; Christopher Changchien; Michael R Peterson; Yuko Kono; Heather Patton; Benjamin L Cohen; David Brenner; Claude Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

View more
  26 in total

1.  Progress in non-invasive detection of liver fibrosis.

Authors:  Chengxi Li; Rentao Li; Wei Zhang
Journal:  Cancer Biol Med       Date:  2018-05       Impact factor: 4.248

2.  Comparison of diffusion-weighted imaging and MR elastography in staging liver fibrosis: a meta-analysis.

Authors:  Weon Jang; Seongil Jo; Ji Soo Song; Hong Pil Hwang; Seong-Hun Kim
Journal:  Abdom Radiol (NY)       Date:  2021-03-26

3.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

Review 4.  Liver intravoxel incoherent motion (IVIM) magnetic resonance imaging: a comprehensive review of published data on normal values and applications for fibrosis and tumor evaluation.

Authors:  Yáo T Li; Jean-Pierre Cercueil; Jing Yuan; Weitian Chen; Romaric Loffroy; Yì Xiáng J Wáng
Journal:  Quant Imaging Med Surg       Date:  2017-02

Review 5.  Diffusion-weighted MRI of the liver: challenges and some solutions for the quantification of apparent diffusion coefficient and intravoxel incoherent motion.

Authors:  Yi Xiang J Wang; Hua Huang; Cun-Jing Zheng; Ben-Heng Xiao; Olivier Chevallier; Wei Wang
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-04-15

Review 6.  Magnetic Resonance imaging analysis of liver fibrosis and inflammation: overwhelming gray zones restrict clinical use.

Authors:  D Marti-Aguado; A Rodríguez-Ortega; A Alberich-Bayarri; L Marti-Bonmati
Journal:  Abdom Radiol (NY)       Date:  2020-08-28

Review 7.  Topics on quantitative liver magnetic resonance imaging.

Authors:  Yì Xiáng J Wáng; Xiaoqi Wang; Peng Wu; Yajie Wang; Weibo Chen; Huijun Chen; Jianqi Li
Journal:  Quant Imaging Med Surg       Date:  2019-11

8.  Liver histology and diffusion-weighted MRI in children with nonalcoholic fatty liver disease: A MAGNET study.

Authors:  Paul Manning; Paul Murphy; Kang Wang; Jonathan Hooker; Tanya Wolfson; Michael S Middleton; Kimberly P Newton; Cynthia Behling; Hannah I Awai; Janis Durelle; Melissa N Paiz; Jorge E Angeles; Diana De La Pena; J Allen McCutchan; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2017-02-22       Impact factor: 4.813

9.  Prospective comparison of magnetic resonance imaging to transient elastography and serum markers for liver fibrosis detection.

Authors:  Hadrien A Dyvorne; Guido H Jajamovich; Octavia Bane; M Isabel Fiel; Hsin Chou; Thomas D Schiano; Douglas Dieterich; James S Babb; Scott L Friedman; Bachir Taouli
Journal:  Liver Int       Date:  2016-02-07       Impact factor: 5.828

10.  Spatially-constrained probability distribution model of incoherent motion (SPIM) for abdominal diffusion-weighted MRI.

Authors:  Sila Kurugol; Moti Freiman; Onur Afacan; Jeannette M Perez-Rossello; Michael J Callahan; Simon K Warfield
Journal:  Med Image Anal       Date:  2016-04-01       Impact factor: 8.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.